Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diphtheria-Tetanus-acellular Pertussis Vaccines | 9 | 2024 | 38 | 4.790 |
Why?
|
Immunization Schedule | 15 | 2020 | 227 | 2.870 |
Why?
|
Vaccination | 19 | 2024 | 3368 | 2.250 |
Why?
|
Whooping Cough | 7 | 2024 | 86 | 1.470 |
Why?
|
Jaundice, Neonatal | 8 | 2005 | 71 | 1.390 |
Why?
|
Pediatrics | 17 | 2022 | 3589 | 1.350 |
Why?
|
Influenza Vaccines | 9 | 2023 | 767 | 1.330 |
Why?
|
Immunization | 9 | 2019 | 1218 | 1.320 |
Why?
|
Influenza, Human | 7 | 2023 | 1521 | 1.250 |
Why?
|
Postpartum Period | 7 | 2020 | 1178 | 1.230 |
Why?
|
Immunization Programs | 5 | 2021 | 267 | 1.080 |
Why?
|
Mandatory Programs | 2 | 2021 | 86 | 1.080 |
Why?
|
Child Health Services | 4 | 2020 | 644 | 0.930 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 10 | 2010 | 52 | 0.920 |
Why?
|
Bites and Stings | 7 | 2007 | 93 | 0.830 |
Why?
|
Infant Care | 2 | 2020 | 180 | 0.820 |
Why?
|
Tetanus Toxoid | 5 | 2017 | 188 | 0.780 |
Why?
|
Vaccines, Combined | 5 | 2017 | 70 | 0.760 |
Why?
|
Haemophilus Vaccines | 9 | 2010 | 71 | 0.750 |
Why?
|
Patient Discharge | 5 | 2020 | 3441 | 0.720 |
Why?
|
Oral Health | 3 | 2017 | 492 | 0.710 |
Why?
|
Bacterial Vaccines | 4 | 2019 | 399 | 0.670 |
Why?
|
Chickenpox Vaccine | 7 | 2008 | 40 | 0.620 |
Why?
|
Antibodies, Bacterial | 11 | 2017 | 1463 | 0.600 |
Why?
|
Health Planning Guidelines | 2 | 2009 | 151 | 0.600 |
Why?
|
Haemophilus influenzae type b | 1 | 2017 | 16 | 0.600 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.600 |
Why?
|
Anemia, Iron-Deficiency | 3 | 2008 | 369 | 0.560 |
Why?
|
Computer-Assisted Instruction | 2 | 2012 | 362 | 0.560 |
Why?
|
Prenatal Care | 1 | 2024 | 1141 | 0.530 |
Why?
|
Oseltamivir | 1 | 2016 | 75 | 0.530 |
Why?
|
Reticulocytes | 2 | 2008 | 288 | 0.530 |
Why?
|
Clinical Competence | 6 | 2017 | 4786 | 0.510 |
Why?
|
Poliovirus Vaccine, Inactivated | 3 | 2010 | 24 | 0.500 |
Why?
|
Infant, Newborn | 22 | 2022 | 26187 | 0.490 |
Why?
|
Point-of-Care Systems | 1 | 2024 | 1213 | 0.490 |
Why?
|
Health Promotion | 6 | 2017 | 2205 | 0.460 |
Why?
|
Maternal Health Services | 3 | 2012 | 460 | 0.460 |
Why?
|
Pneumococcal Vaccines | 5 | 2010 | 397 | 0.460 |
Why?
|
Antibody Formation | 4 | 2017 | 1391 | 0.440 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2013 | 111 | 0.430 |
Why?
|
Pandemics | 3 | 2022 | 8663 | 0.400 |
Why?
|
Education, Medical, Continuing | 3 | 2011 | 825 | 0.400 |
Why?
|
Patient Education as Topic | 4 | 2017 | 2316 | 0.380 |
Why?
|
Infant | 39 | 2022 | 36164 | 0.380 |
Why?
|
Meningococcal Vaccines | 5 | 2017 | 94 | 0.380 |
Why?
|
Hemoglobins | 2 | 2008 | 1525 | 0.360 |
Why?
|
Pregnancy | 9 | 2024 | 29872 | 0.360 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2022 | 2150 | 0.350 |
Why?
|
Erythrocyte Indices | 2 | 2008 | 144 | 0.350 |
Why?
|
Self Report | 1 | 2021 | 3728 | 0.330 |
Why?
|
Mothers | 3 | 2022 | 2193 | 0.330 |
Why?
|
New York City | 2 | 2022 | 730 | 0.330 |
Why?
|
Child | 27 | 2024 | 80134 | 0.320 |
Why?
|
Pertussis Vaccine | 3 | 2022 | 39 | 0.310 |
Why?
|
Health Communication | 1 | 2011 | 212 | 0.310 |
Why?
|
Social Marketing | 1 | 2008 | 52 | 0.300 |
Why?
|
Hearing Loss, Conductive | 1 | 2009 | 159 | 0.300 |
Why?
|
Drug Storage | 2 | 2007 | 52 | 0.300 |
Why?
|
Refrigeration | 1 | 2007 | 27 | 0.290 |
Why?
|
Mass Vaccination | 1 | 2009 | 109 | 0.290 |
Why?
|
Hyperbilirubinemia, Neonatal | 1 | 2007 | 30 | 0.290 |
Why?
|
Curriculum | 5 | 2017 | 3739 | 0.290 |
Why?
|
Measles-Mumps-Rubella Vaccine | 2 | 2007 | 71 | 0.280 |
Why?
|
Dogs | 5 | 2007 | 3832 | 0.270 |
Why?
|
Viral Vaccines | 2 | 2007 | 593 | 0.270 |
Why?
|
Humans | 79 | 2024 | 761098 | 0.270 |
Why?
|
Bordetella pertussis | 4 | 1995 | 45 | 0.270 |
Why?
|
Pregnant Women | 2 | 2022 | 567 | 0.260 |
Why?
|
United States | 19 | 2023 | 72337 | 0.260 |
Why?
|
Primary Health Care | 3 | 2020 | 4673 | 0.250 |
Why?
|
Reminder Systems | 2 | 2017 | 386 | 0.250 |
Why?
|
Quality Improvement | 2 | 2019 | 3801 | 0.250 |
Why?
|
Internship and Residency | 6 | 2017 | 5879 | 0.250 |
Why?
|
Child Welfare | 2 | 2008 | 521 | 0.230 |
Why?
|
Health Personnel | 2 | 2010 | 3335 | 0.220 |
Why?
|
Certification | 1 | 2007 | 418 | 0.220 |
Why?
|
Electronic Health Records | 1 | 2021 | 4813 | 0.220 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2009 | 781 | 0.210 |
Why?
|
Child, Preschool | 23 | 2019 | 42217 | 0.210 |
Why?
|
Thermometers | 1 | 2002 | 42 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3094 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3216 | 0.200 |
Why?
|
Vaccines | 2 | 2019 | 835 | 0.190 |
Why?
|
Hepatitis B Vaccines | 3 | 2007 | 177 | 0.190 |
Why?
|
Disease Reservoirs | 1 | 2001 | 121 | 0.190 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2013 | 2518 | 0.180 |
Why?
|
Health Behavior | 1 | 2012 | 2641 | 0.180 |
Why?
|
Female | 35 | 2024 | 392458 | 0.180 |
Why?
|
Vaccines, Conjugate | 6 | 2010 | 328 | 0.180 |
Why?
|
Attitude of Health Personnel | 3 | 2003 | 3882 | 0.180 |
Why?
|
Learning | 2 | 2014 | 1739 | 0.180 |
Why?
|
Hepatitis A Vaccines | 3 | 2006 | 26 | 0.180 |
Why?
|
Office Visits | 3 | 2017 | 594 | 0.180 |
Why?
|
Fever | 4 | 2007 | 1618 | 0.180 |
Why?
|
Antibodies, Viral | 4 | 2010 | 3149 | 0.170 |
Why?
|
Tetanus | 2 | 2017 | 51 | 0.170 |
Why?
|
Health Services Research | 1 | 2008 | 1807 | 0.170 |
Why?
|
Hypercholesterolemia | 1 | 2007 | 1141 | 0.170 |
Why?
|
Cholesterol, LDL | 2 | 2007 | 2380 | 0.170 |
Why?
|
Haemophilus Infections | 2 | 2017 | 94 | 0.170 |
Why?
|
Rotavirus Vaccines | 3 | 2007 | 62 | 0.170 |
Why?
|
Advisory Committees | 4 | 2019 | 788 | 0.160 |
Why?
|
Virus Diseases | 1 | 2005 | 716 | 0.160 |
Why?
|
Mass Screening | 2 | 2007 | 5425 | 0.160 |
Why?
|
Virulence Factors, Bordetella | 2 | 1995 | 154 | 0.160 |
Why?
|
Bilirubin | 3 | 2007 | 435 | 0.160 |
Why?
|
Needs Assessment | 2 | 2004 | 1139 | 0.160 |
Why?
|
Practice Guidelines as Topic | 4 | 2009 | 7400 | 0.160 |
Why?
|
Health Education | 1 | 2005 | 1049 | 0.150 |
Why?
|
Parents | 2 | 2024 | 3564 | 0.150 |
Why?
|
Sudden Infant Death | 1 | 2001 | 292 | 0.150 |
Why?
|
Health Care Surveys | 3 | 2021 | 2424 | 0.150 |
Why?
|
Diphtheria | 1 | 2017 | 33 | 0.150 |
Why?
|
Mental Recall | 1 | 2024 | 1221 | 0.150 |
Why?
|
Vaccines, Acellular | 1 | 2017 | 11 | 0.140 |
Why?
|
Program Evaluation | 3 | 2017 | 2487 | 0.140 |
Why?
|
Logistic Models | 4 | 2021 | 13254 | 0.140 |
Why?
|
Haemophilus influenzae | 3 | 1993 | 178 | 0.140 |
Why?
|
Breast Feeding | 2 | 2022 | 1355 | 0.140 |
Why?
|
Papillomavirus Vaccines | 2 | 2017 | 496 | 0.140 |
Why?
|
Nursing Care | 1 | 2017 | 65 | 0.130 |
Why?
|
Polysaccharides, Bacterial | 4 | 2007 | 577 | 0.130 |
Why?
|
Teaching | 3 | 2014 | 1169 | 0.130 |
Why?
|
Viral Hepatitis Vaccines | 2 | 2007 | 72 | 0.130 |
Why?
|
Perception | 1 | 2002 | 1198 | 0.130 |
Why?
|
Cricetulus | 1 | 2017 | 812 | 0.130 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 2372 | 0.130 |
Why?
|
School Health Services | 2 | 2017 | 384 | 0.130 |
Why?
|
Diphtheria Toxoid | 2 | 1994 | 26 | 0.120 |
Why?
|
Health Status | 2 | 2012 | 4077 | 0.120 |
Why?
|
CHO Cells | 1 | 2017 | 1379 | 0.120 |
Why?
|
Hyperbilirubinemia | 2 | 2005 | 74 | 0.120 |
Why?
|
Multivariate Analysis | 3 | 2021 | 12058 | 0.120 |
Why?
|
Guidelines as Topic | 1 | 2001 | 1386 | 0.120 |
Why?
|
Prospective Studies | 9 | 2022 | 54419 | 0.120 |
Why?
|
New York | 1 | 2017 | 875 | 0.120 |
Why?
|
Adolescent | 9 | 2021 | 88271 | 0.120 |
Why?
|
Chickenpox | 2 | 1997 | 96 | 0.110 |
Why?
|
Clostridium tetani | 2 | 1993 | 5 | 0.110 |
Why?
|
Corynebacterium diphtheriae | 2 | 1993 | 21 | 0.110 |
Why?
|
Decision Making | 1 | 2007 | 3925 | 0.110 |
Why?
|
Animals, Domestic | 2 | 2004 | 56 | 0.110 |
Why?
|
Mumps Vaccine | 2 | 2008 | 16 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2001 | 873 | 0.100 |
Why?
|
Herpesvirus 3, Human | 1 | 1993 | 159 | 0.100 |
Why?
|
Adult | 13 | 2024 | 221083 | 0.100 |
Why?
|
Fetal Blood | 2 | 2013 | 1347 | 0.100 |
Why?
|
Young Adult | 4 | 2024 | 59199 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2017 | 4013 | 0.100 |
Why?
|
Child Abuse | 1 | 2001 | 1076 | 0.100 |
Why?
|
Salmonella Infections | 2 | 2005 | 172 | 0.100 |
Why?
|
Medical Order Entry Systems | 1 | 2017 | 521 | 0.100 |
Why?
|
Dental Caries | 1 | 2015 | 427 | 0.090 |
Why?
|
Sampling Studies | 2 | 2002 | 615 | 0.090 |
Why?
|
Antigens, Bacterial | 3 | 2002 | 1140 | 0.090 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2010 | 33 | 0.090 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26068 | 0.090 |
Why?
|
Hepatitis A | 2 | 2007 | 127 | 0.090 |
Why?
|
Measles Vaccine | 2 | 2004 | 79 | 0.080 |
Why?
|
Cats | 2 | 2001 | 974 | 0.080 |
Why?
|
Otoscopy | 1 | 2009 | 40 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2577 | 0.080 |
Why?
|
Male | 22 | 2017 | 360675 | 0.080 |
Why?
|
Universal Precautions | 1 | 2009 | 34 | 0.080 |
Why?
|
Immunity, Herd | 1 | 2009 | 46 | 0.080 |
Why?
|
Hearing Tests | 1 | 2009 | 121 | 0.080 |
Why?
|
Audiometry | 1 | 2009 | 253 | 0.080 |
Why?
|
Public Health | 1 | 2022 | 2671 | 0.080 |
Why?
|
Caregivers | 1 | 2020 | 2241 | 0.080 |
Why?
|
Streptococcal Vaccines | 1 | 2008 | 44 | 0.080 |
Why?
|
Biomedical Research | 1 | 2003 | 3429 | 0.070 |
Why?
|
Polysaccharide-Lyases | 1 | 1987 | 47 | 0.070 |
Why?
|
Heparin Antagonists | 1 | 1987 | 34 | 0.070 |
Why?
|
Random Allocation | 2 | 2002 | 2393 | 0.070 |
Why?
|
Blood Cell Count | 1 | 2008 | 396 | 0.070 |
Why?
|
Meningococcal Infections | 1 | 2007 | 77 | 0.070 |
Why?
|
Drug Stability | 1 | 2007 | 288 | 0.070 |
Why?
|
Bacterial Proteins | 4 | 2002 | 3838 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2002 | 3707 | 0.070 |
Why?
|
Phototherapy | 2 | 2007 | 368 | 0.070 |
Why?
|
Rotavirus Infections | 1 | 2007 | 84 | 0.070 |
Why?
|
Ethics Committees, Research | 1 | 2008 | 196 | 0.070 |
Why?
|
Freezing | 1 | 2007 | 311 | 0.070 |
Why?
|
Double-Blind Method | 7 | 2007 | 12341 | 0.070 |
Why?
|
ROC Curve | 2 | 2005 | 3582 | 0.070 |
Why?
|
Snakes | 1 | 2005 | 27 | 0.060 |
Why?
|
Toxoids | 2 | 1995 | 11 | 0.060 |
Why?
|
Specialty Boards | 1 | 2007 | 235 | 0.060 |
Why?
|
Health Status Disparities | 1 | 2017 | 1846 | 0.060 |
Why?
|
Rabies | 1 | 2005 | 54 | 0.060 |
Why?
|
Medication Adherence | 1 | 2017 | 2175 | 0.060 |
Why?
|
Markov Chains | 1 | 2008 | 965 | 0.060 |
Why?
|
Hemagglutinins | 2 | 1995 | 111 | 0.060 |
Why?
|
Perinatal Care | 1 | 2007 | 244 | 0.060 |
Why?
|
Neonatal Screening | 1 | 2009 | 597 | 0.060 |
Why?
|
Adhesins, Bacterial | 2 | 1995 | 118 | 0.060 |
Why?
|
Salmonella Infections, Animal | 1 | 2004 | 60 | 0.060 |
Why?
|
Animals | 9 | 2017 | 168083 | 0.060 |
Why?
|
Antiviral Agents | 1 | 2016 | 3048 | 0.060 |
Why?
|
Sex Distribution | 1 | 2009 | 2278 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2022 | 80673 | 0.060 |
Why?
|
Vaccines, Synthetic | 4 | 2002 | 612 | 0.050 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3238 | 0.050 |
Why?
|
Education, Continuing | 1 | 2004 | 114 | 0.050 |
Why?
|
Age Distribution | 1 | 2009 | 2873 | 0.050 |
Why?
|
Epidemiologic Methods | 1 | 2008 | 1336 | 0.050 |
Why?
|
Fasting | 2 | 2007 | 1603 | 0.050 |
Why?
|
Lipid A | 1 | 2002 | 70 | 0.050 |
Why?
|
Nurseries, Hospital | 1 | 2002 | 17 | 0.050 |
Why?
|
Ferritins | 1 | 2005 | 597 | 0.050 |
Why?
|
Linear Models | 1 | 2012 | 5869 | 0.050 |
Why?
|
Education, Medical | 1 | 2014 | 1725 | 0.050 |
Why?
|
Risk Assessment | 3 | 2015 | 24013 | 0.050 |
Why?
|
Bacterial Outer Membrane Proteins | 2 | 1995 | 404 | 0.050 |
Why?
|
Vaccines, Inactivated | 2 | 2006 | 178 | 0.050 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2002 | 174 | 0.050 |
Why?
|
Hearing Loss | 1 | 2009 | 782 | 0.050 |
Why?
|
Vaccines, Attenuated | 2 | 2012 | 315 | 0.050 |
Why?
|
Cross Infection | 1 | 2010 | 1422 | 0.050 |
Why?
|
Cost-Benefit Analysis | 3 | 2012 | 5494 | 0.050 |
Why?
|
Gilbert Disease | 1 | 2000 | 4 | 0.050 |
Why?
|
Poliovirus Vaccines | 1 | 2000 | 13 | 0.050 |
Why?
|
Algorithms | 1 | 2001 | 14023 | 0.040 |
Why?
|
Bacterial Capsules | 4 | 2007 | 241 | 0.040 |
Why?
|
Health Policy | 2 | 2012 | 2680 | 0.040 |
Why?
|
Heparin | 1 | 1987 | 1632 | 0.040 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2002 | 431 | 0.040 |
Why?
|
Maternal Age | 1 | 2002 | 809 | 0.040 |
Why?
|
Accreditation | 1 | 2002 | 473 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2005 | 14676 | 0.040 |
Why?
|
Education, Medical, Undergraduate | 1 | 2008 | 1071 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10213 | 0.040 |
Why?
|
Cost of Illness | 1 | 2008 | 1937 | 0.040 |
Why?
|
Maternal Welfare | 1 | 1999 | 112 | 0.040 |
Why?
|
Data Collection | 1 | 2008 | 3319 | 0.040 |
Why?
|
Educational Measurement | 1 | 2005 | 1251 | 0.040 |
Why?
|
Rabbits | 1 | 2004 | 4749 | 0.040 |
Why?
|
Complementary Therapies | 1 | 2002 | 486 | 0.040 |
Why?
|
Renal Dialysis | 1 | 1987 | 1796 | 0.040 |
Why?
|
Cohort Studies | 2 | 2012 | 41486 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2002 | 988 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2002 | 976 | 0.030 |
Why?
|
Gestational Age | 1 | 2005 | 3577 | 0.030 |
Why?
|
Physicians, Women | 1 | 2002 | 510 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22157 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2004 | 6224 | 0.030 |
Why?
|
Medication Errors | 1 | 2001 | 783 | 0.030 |
Why?
|
Medical Records Systems, Computerized | 1 | 2001 | 1191 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2000 | 771 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2001 | 3419 | 0.030 |
Why?
|
Societies, Medical | 1 | 2007 | 3923 | 0.030 |
Why?
|
Rubella Vaccine | 1 | 1993 | 23 | 0.030 |
Why?
|
Poliovirus Vaccine, Oral | 1 | 1993 | 25 | 0.030 |
Why?
|
Central Nervous System Stimulants | 1 | 2002 | 1176 | 0.030 |
Why?
|
Pneumonia | 1 | 2004 | 2142 | 0.030 |
Why?
|
Staff Development | 1 | 2014 | 227 | 0.030 |
Why?
|
Latex Fixation Tests | 1 | 1991 | 29 | 0.020 |
Why?
|
Immunization, Secondary | 1 | 1994 | 366 | 0.020 |
Why?
|
Drugs, Investigational | 1 | 1993 | 212 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 1999 | 1401 | 0.020 |
Why?
|
Incidence | 1 | 2009 | 21357 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2009 | 39121 | 0.020 |
Why?
|
Family | 1 | 2001 | 3193 | 0.020 |
Why?
|
Internet | 1 | 2002 | 3094 | 0.020 |
Why?
|
Attitude | 1 | 2014 | 772 | 0.020 |
Why?
|
Physicians | 1 | 2007 | 4583 | 0.020 |
Why?
|
Length of Stay | 1 | 2002 | 6420 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 1993 | 1527 | 0.020 |
Why?
|
Sex Factors | 1 | 2002 | 10552 | 0.020 |
Why?
|
Massachusetts | 1 | 2001 | 8836 | 0.020 |
Why?
|
Flavobacterium | 1 | 1987 | 20 | 0.020 |
Why?
|
Heparin Lyase | 1 | 1987 | 37 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2002 | 20120 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1505 | 0.020 |
Why?
|
Immunoglobulin G | 2 | 2002 | 4538 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2012 | 803 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2002 | 12975 | 0.020 |
Why?
|
Hematologic Tests | 1 | 1987 | 239 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2002 | 8000 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2012 | 934 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2012 | 1723 | 0.020 |
Why?
|
Registries | 1 | 2001 | 8236 | 0.020 |
Why?
|
Prevalence | 1 | 2002 | 15717 | 0.020 |
Why?
|
Sheep | 1 | 1987 | 1436 | 0.010 |
Why?
|
Diet | 1 | 2002 | 8047 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2007 | 1577 | 0.010 |
Why?
|
Aluminum Compounds | 1 | 2002 | 55 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3689 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2009 | 64670 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2007 | 2927 | 0.010 |
Why?
|
Immunity | 1 | 2007 | 996 | 0.010 |
Why?
|
Autoanalysis | 1 | 2000 | 70 | 0.010 |
Why?
|
Surface-Active Agents | 1 | 2000 | 150 | 0.010 |
Why?
|
Equipment Design | 1 | 1987 | 3509 | 0.010 |
Why?
|
Phosphates | 1 | 2002 | 763 | 0.010 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2000 | 239 | 0.010 |
Why?
|
Communication | 1 | 2012 | 3852 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2002 | 1553 | 0.010 |
Why?
|
Boston | 2 | 2000 | 9324 | 0.010 |
Why?
|
Heating | 1 | 1997 | 104 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 1996 | 555 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2002 | 1803 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 1996 | 672 | 0.010 |
Why?
|
Rubella virus | 1 | 1993 | 11 | 0.010 |
Why?
|
Risk Factors | 1 | 2001 | 74219 | 0.010 |
Why?
|
Mumps virus | 1 | 1993 | 23 | 0.010 |
Why?
|
Measles virus | 1 | 1993 | 67 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2000 | 1812 | 0.010 |
Why?
|
Eating | 1 | 2000 | 1535 | 0.010 |
Why?
|
Poliovirus | 1 | 1993 | 106 | 0.010 |
Why?
|
Anorexia | 1 | 1993 | 153 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1994 | 641 | 0.010 |
Why?
|
Reference Values | 1 | 2000 | 4922 | 0.010 |
Why?
|
Time Factors | 2 | 1991 | 39953 | 0.010 |
Why?
|
Triglycerides | 1 | 2000 | 2457 | 0.010 |
Why?
|
Irritable Mood | 1 | 1993 | 193 | 0.010 |
Why?
|
Erythema | 1 | 1993 | 262 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2002 | 5478 | 0.010 |
Why?
|
Japan | 1 | 1996 | 1373 | 0.010 |
Why?
|
Cholesterol | 1 | 2000 | 2902 | 0.010 |
Why?
|
Regression Analysis | 1 | 2000 | 6343 | 0.010 |
Why?
|
Sleep Stages | 1 | 1993 | 695 | 0.010 |
Why?
|
Safety | 1 | 1993 | 1151 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1987 | 18217 | 0.000 |
Why?
|
Antigens | 1 | 1993 | 1441 | 0.000 |
Why?
|
Drug Monitoring | 1 | 1994 | 961 | 0.000 |
Why?
|
Cytokines | 1 | 2002 | 7386 | 0.000 |
Why?
|
Drug Combinations | 1 | 1993 | 2048 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1993 | 3803 | 0.000 |
Why?
|
Immunologic Memory | 1 | 1991 | 1361 | 0.000 |
Why?
|
Age Factors | 1 | 1993 | 18385 | 0.000 |
Why?
|